Selected article for: "development risk factor and risk factor"
Title: Proceedings 31st Symposium ESVN-ECVN
  • Document date: 2019_12_21
    • ID: 4526ne4l_179
    Snippet: In this study, phenobarbitone dose was the most significant risk factor for the development of the most commonly encountered adverse effects (sedation and ataxia)......
    Document: In this study, phenobarbitone dose was the most significant risk factor for the development of the most commonly encountered adverse effects (sedation and ataxia).

    Search related documents:
    Co phrase search for related documents
    • adverse effect and phenobarbitone dose: 1
    • adverse effect and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • ataxia sedation and phenobarbitone dose: 1